NSD2 and neoplasm: Genetic ablation of WHSC1 impairs IFN-γ-induced antigen presentation, accelerates tumor growth in immune-competent hosts, and diminishes checkpoint efficacy, indicating that sustaining or activating WHSC1 may convert “cold” tumors into immunotherapy-responsive phenotypes [107].